/// IKA-Werke is expanding its portfolio of temperature chambers with an environmentally friendly and resource-saving cooled incubator. The new INC 125 FC digital complements the existing models, the classic INC 125 F digital incubator and the INC 125 FS digital incubator shaker with its patented removable shaking platform. All devices in the series are ideal [...]

High-throughput, easy to automate and affordable plasma proteomics with quantitative precision ENRICHplus enables deep access to the plasma proteome by up to 7-fold increased protein identifications compared to neat plasma, with outstanding reproducibility (e.g., CV 11%) ENRICHplus enabled the identification of a cumulative 5,800 protein groups in a small clinical study (6 healthy donors, 6 [...]

LOWER GWYNEDD, Pa. -- ChromaTan, a bioprocessing and biotools advanced biomanufacturing technology platform development company, is excited to announce the award of NIH IIB grant of $2M from the National Institute of General Medical Sciences, for the development and integration of ChromaTan’s novel BioRMB™ single-use, column-free, steady-state continuous counter-current elution technology for manufacturing AAVs. This project [...]

Applied Biosystems™ CytoScan™ Dx and Chromosome Analysis Suite (ChAS) Dx software provide complete solution to support cytogenetic testing CARLSBAD, Calif. --  Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic [...]

Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digitial Insight solutions, and Myriad’s proprietary, FDA-approved MyChoice CDx® biomarkers QIAGEN to make kit-based HRD test available globally to support research and companion diagnostics development in collaboration with pharmaceutical partners enabling wider adoption and potential clinical indication expansion for MyChoice CDx Project [...]

Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery® P2 Plasma Enrichment method offers market-leading performance and superior economics for unbiased, deep plasma proteomics  New TrueTarget® high-throughput LiP-MS workflow enables large-scale drug target deconvolution screening with improved target identification DigitalProteome™ database and Proteoverse™ data exploration tool help [...]

City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program Cambridge, UK – CUNY (City University of New York) and Genestack Ltd are pleased to announce their collaboration aimed at streamlining data curation for the BioConductor program. This innovative partnership brings together the expertise of CUNY [...]

Latest release expedites review of large data sets and offers new protein characterization functionalities for disulfide bond mapping and top-down mass spectrometry Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist ® 18.0, its platform for streamlining and automating characterization and quality monitoring [...]

The proprietary P2 Plasma Enrichment method leverages a novel single-well, single particle-type enrichment method to achieve market-leading performance for unbiased, deep mass spectrometry-based plasma proteomics  P2 now offers excellent quantitation and higher throughput for large-cohort biomarker or drug discovery studies, and clinical, epidemiological or population proteomics research P2 Plasma Enrichment is available as a CRO [...]

BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Charles (“Chuck”) Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During [...]